Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
CNS Oncology|November 4, 2014
Antiangiogenic therapies for glioblastomaIsabel Arrillaga-Romany, Andrew D NordenPlanta Medica|March 8, 2003
Agrobacterium tumefaciens-mediated genetic transformation of the cardenolide-producing plant Digitalis minor LEster Sales, Juan Segura, Isabel ArrillagaPlant Cell Reports|February 24, 2006
In vitro storage of cedar shoot cultures under minimal growth conditionsBegoña Renau-Morata, Isabel Arrillaga, Juan SeguraTree Physiology|February 3, 2005
Factors influencing axillary shoot proliferation and adventitious budding in cedarBegoña Renau-Morata, Javier Ollero, Isabel Arrillaga, et al.Metabolic Engineering|June 3, 2008
Expression of spearmint limonene synthase in transgenic spike lavender results in an altered monoterpene composition in developing leavesJesús Muñoz-Bertomeu, Roc Ros, Isabel Arrillaga, et al.Planta Medica|May 23, 2007
Enhancement of cardenolide and phytosterol levels by expression of an N-terminally truncated 3-hydroxy-3-methylglutaryl CoA reductase in Transgenic digitalis minorEster Sales, Jesús Muñoz-Bertomeu, Isabel Arrillaga, et al.Plant Physiology|September 19, 2006
Up-regulation of 1-deoxy-D-xylulose-5-phosphate synthase enhances production of essential oils in transgenic spike lavenderJesús Muñoz-Bertomeu, Isabel Arrillaga, Roc Ros, et al.Expert Opinion on Investigational Drugs|December 11, 2013
Current status of antiangiogenic therapies for glioblastomasIsabel Arrillaga-Romany, David A Reardon, Patrick Y WenJournal of Plant Physiology|August 25, 2014
Deoxyxylulose 5-phosphate reductoisomerase is not a rate-determining enzyme for essential oil production in spike lavenderIsabel Mendoza-Poudereux, Jesús Muñoz-Bertomeu, Isabel Arrillaga, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 10, 2026
Approved Targeted Treatments for Pediatric Brain TumorsEric Bouffet, David Neal Franz, Isabel Arrillaga-Romany, et al.Pageof 6